Study authors enrolled 93 patients who underwent one-level to two-level TLIFs between 2011 and 2014. Patients were divided two groups: those who used opioids preoperatively and those who did not.
Clinical scoring for the groups were conducted preoperatively and at a 12 month follow-up examination.
Here’s what you need to know.
1. Of all the participants, 60 patients took prescribed opioid medication prior to undergoing surgery.
2. The 60 patients who took opioids preoperative showed significantly higher scores for lower back pain (0.016) , greater disability (0.013) and lower physical component summary scores (0.03) at the follow-
up visit.
3. Postoperative mental component summary scores were lower in the group that did not take opioids before surgery.
4. There was no detection of opioid dose-related effects on leg and back pain, disability and component summary score, suggesting worse outcomes are not correlated with higher doses of opioid doses.
5. Study authors concluded, “The use of opioid medications to control pain before patients underwent lumbar fusion for degenerative lumbar conditions was associated with less favorable clinical outcomes
postoperatively.”
More articles on spine:
5 trends in the spine surgery market
Drs. Jim Maxwell, Howard Eisenbrock & more: 6 spine, neurosurgeons making headlines
Neurosurgeon Dr. Pradeep Setty named a 2018 Top Doctor — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.